Metabolic Functions of G Protein-Coupled Receptors and β-Arrestin-Mediated Signaling Pathways in the Pathophysiology of Type 2 Diabetes and Obesity.
Metabolic Functions of G Protein-Coupled Receptors and β-Arrestin-Mediated Signaling Pathways in the Pathophysiology of Type 2 Diabetes and Obesity.
复制标题
DOI:
10.3389/fendo.2021.715877
复制
发表时间:
2021
影响因子:
5.2
通讯作者:
Oh D
中科院分区:
文献类型:
--
作者:
Oliveira de Souza C;Sun X;Oh D
Seven transmembrane receptors (7TMRs), often termed G protein-coupled receptors (GPCRs), are the most common target of therapeutic drugs used today. Many studies suggest that distinct members of the GPCR superfamily represent potential targets for the treatment of various metabolic disorders including obesity and type 2 diabetes (T2D). GPCRs typically activate different classes of heterotrimeric G proteins, which can be subgrouped into four major functional types: Gαs, Gαi, Gαq/11, and G12/13, in response to agonist binding. Accumulating evidence suggests that GPCRs can also initiate β-arrestin-dependent, G protein-independent signaling. Thus, the physiological outcome of activating a certain GPCR in a particular tissue may also be modulated by β-arrestin-dependent, but G protein-independent signaling pathways. In this review, we will focus on the role of G protein- and β-arrestin-dependent signaling pathways in the development of obesity and T2D-related metabolic disorders.
登录
查看更多内容
DOI:
10.1074/jbc.m116.754887
发表时间:
2016-12-30
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Alvarez-Curto E;Inoue A;Jenkins L;Raihan SZ;Prihandoko R;Tobin AB;Milligan G
通讯作者:
Milligan G
影响因子:
4.6
作者:
Ang Z;Er JZ;Ding JL
通讯作者:
Ding JL
DOI:
10.1152/ajpendo.00229.2010
发表时间:
2011-01-01
影响因子:
5.1
作者:
Bjursell, Mikael;Admyre, Therese;Bohlooly-Y, Mohammad
通讯作者:
Bohlooly-Y, Mohammad
影响因子:
4.8
作者:
Brown, AJ;Goldsworthy, SM;Dowell, SJ
通讯作者:
Dowell, SJ
影响因子:
4.8
作者:
Farilla, L;Bulotta, A;Perfetti, R
通讯作者:
Perfetti, R